The Safety Rates Drug Report

Member Login
2004.Q1    2004.Q2    2004.Q3    2004.Q4    2005.Q1    2005.Q2    2005.Q3    2005.Q4    2006.Q1    2006.Q2    2006.Q3    2006.Q4    2007.Q1    2007.Q2    2007.Q3    2007.Q4    2008.Q1    2008.Q2    2008.Q3    2008.Q4    2009.Q1    2009.Q2    2009.Q3    2009.Q4    2010.Q1    2010.Q2    2010.Q3    2010.Q4    2011.Q1    2011.Q2    2011.Q3    2011.Q4    2012.Q1    2012.Q2    2012.Q3    2012.Q4    2013.Q1    2013.Q2    2013.Q3    2013.Q4    2014.Q1    2014.Q2    2014.Q3    2014.Q4    2015.Q1    2015.Q2    2015.Q3    2015.Q4    2016.Q1    2016.Q2    2016.Q3   

Drug     Injury     Quarter    

Drug: gemcitabine     Quarter: 2016Q3

Total Records: 1,060     Number of Pages: 53

DRUGNAME PT EventCount
GEMCITABINE HYDROCHLORIDE. Chest pain 4
GEMCITABINE HYDROCHLORIDE. Deep vein thrombosis 4
GEMCITABINE HYDROCHLORIDE. Device related infection 4
GEMCITABINE HYDROCHLORIDE. General physical health deterioration 4
GEMCITABINE HYDROCHLORIDE. Haemolytic uraemic syndrome 4
GEMCITABINE HYDROCHLORIDE. Infection 4
GEMCITABINE HYDROCHLORIDE. Metastases to liver 4
GEMCITABINE HYDROCHLORIDE. Neoplasm progression 4
GEMCITABINE HYDROCHLORIDE. Neutropenic sepsis 4
GEMCITABINE HYDROCHLORIDE. Pancreatic insufficiency 4
GEMCITABINE HYDROCHLORIDE. Pancytopenia 4
GEMCITABINE HYDROCHLORIDE. Pruritus 4
GEMCITABINE HYDROCHLORIDE. Small intestinal obstruction 4
GEMCITABINE HYDROCHLORIDE. Urinary tract infection 4
GEMCITABINE HYDROCHLORIDE. Vocal cord paralysis 4
GEMCITABINE HYDROCHLORIDE. Weight decreased 4
GEMCITABINE/GEMCITABINE HYDROCHLORIDE Decreased appetite 4
GEMCITABINE/GEMCITABINE HYDROCHLORIDE Haematotoxicity 4
GEMCITABINE Adenocarcinoma pancreas 3
GEMCITABINE Alopecia 3

Total Records: 1,060     Number of Pages: 53